ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded prescription medications. With a focus on complex formulations, ANI Pharmaceuticals serves a diverse range of therapeutic areas, including pain management, oncology, and anti-infectives. The company’s commitment to innovation is evident in its extensive portfolio of products, which includes unique formulations that address unmet medical needs. ANI Pharmaceuticals has achieved significant milestones, including strategic acquisitions that have expanded its operational footprint across major regions in the US. With a strong market position and a dedication to quality, ANI Pharmaceuticals continues to make a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does ANI Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ANI Pharmaceuticals, Inc.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ANI Pharmaceuticals, Inc.'s reported carbon emissions
ANI Pharmaceuticals, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions data, it is challenging to assess their carbon footprint or climate commitments accurately. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions. Companies are encouraged to adopt science-based targets and engage in initiatives that promote environmental responsibility. ANI Pharmaceuticals may be exploring such commitments in line with industry trends, but specific details are not available at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ANI Pharmaceuticals, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
